Hepatitis/MASH

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

X-ray image of liver -- Image credit: Sebastian Kaulitzki | stock.adobe.com
BEAM-302 Receives FDA IND Clearance for AATD, a Genetic Disorder Affecting the Liver and Lungs

March 31st 2025

Currently, BEAM-302 is undergoing a phase 1/2 clinical trial to evaluate its efficacy in patients with alpha-1 antitrypsin deficiency (AATD) who have lung disease and liver disease.

Health care professional preparing antigen test -- Image credit: nito | stock.adobe.com
HBcrAg Rapid Diagnostic Test Shows Potential in Timely Detection of HBV DNA Concentrations

March 26th 2025

Pharmacist preparing vaccination -- Image credit: PEDROMERINO | stock.adobe.com
Hecolin HEV Vaccination Shows Safety and Immunogenicity in Patients With CHB

March 18th 2025

X-ray image of human liver -- Image credit: magicmine | stock.adobe.com
DC646 Shows Promise as a Therapeutic Approach for MASH

March 14th 2025

Health care professional showing patient a model of a liver -- Image credit: Peakstock | stock.adobe.com
Lipid Biology Helps Distinguish Hepatitis From Cirrhosis and Identifies 90-Day Mortality

March 12th 2025

More News

Site Logo

Specialty Pharmaceuticals: Hepatitis C Update

Todd Cooperman, PharmD, RPh, PAHM;Russel Allinson, RPh, MS
February 8th 2011

Researchers assess new study models and investigate triple drug therapies to fight hepatitis C infection.

Read More

Site Logo

Counseling Patients with the Difficult Diagnosis of Hepatitis C

Yvette C. Terrie, BSPharm, RPh
February 15th 2010

Hepatitis C can be a challenging disease for patients. Pharmacists can be instrumental in educating their patients about the pharmacologic agents available for treatment and provide them with valuable resources to successfully manage this condition.

Read More

<1
...
3536373839